AAAAAA
Results:
1-11
|
Results: 11
Authors:
Conte, PF
Gadducci, A
Cianci, C
Citation: Pf. Conte et al., Second-line treatment and consolidation therapies in advanced ovarian cancer, INT J GYN C, 11, 2001, pp. 52-56
Authors:
Deshpande, MS
Wei, JM
Luo, GX
Cianci, C
Danetz, S
Torri, A
Tiley, L
Krystal, M
Yu, KL
Huang, S
Gao, Q
Meanwell, NA
Citation: Ms. Deshpande et al., An approach to the identification of potent inhibitors of influenza virus fusion using parallel synthesis methodology, BIOORG MED, 11(17), 2001, pp. 2393-2396
Authors:
Combrink, KD
Gulgeze, HB
Yu, KL
Pearce, BC
Trehan, AK
Wei, JM
Deshpande, M
Krystal, M
Torri, A
Luo, GX
Cianci, C
Danetz, S
Tiley, L
Meanwell, NA
Citation: Kd. Combrink et al., Salicylamide inhibitors of influenza virus fusion, BIOORG MED, 10(15), 2000, pp. 1649-1652
Authors:
Conte, PF
Cianci, C
Tanganelli, L
Gadducci, A
Citation: Pf. Conte et al., Ovarian cancer: optimal chemotherapy in relapsed disease, ANN ONCOL, 11, 2000, pp. 145-150
Authors:
Gadducci, A
Cianci, C
Cosio, S
Carnino, F
Fanucchi, A
Buttitta, F
Conte, PF
Genazzani, AR
Citation: A. Gadducci et al., p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen, ANTICANC R, 20(6C), 2000, pp. 4793-4799
Authors:
Yu, KL
Ruediger, E
Luo, GX
Cianci, C
Danetz, S
Tiley, L
Trehan, AK
Monkovic, I
Pearce, B
Martel, A
Krystal, M
Meanwell, NA
Citation: Kl. Yu et al., Novel quinolizidine salicylamide influenza fusion inhibitors, BIOORG MED, 9(15), 1999, pp. 2177-2180
Authors:
Dischino, DD
Cianci, C
Krystal, M
Meanwell, NA
Morimoto, H
Pearce, BC
Williams, P
Yu, KL
Citation: Dd. Dischino et al., Synthesis of H-3-labeled 2-hydroxy-N-[(1,3,3-trimethyl-[4,5,6-H-3]cyclohexyl)methyl]-5-azidobenzamide, a photoaffinity analog of an influenza fusion inhibitor, J LABEL C R, 42(10), 1999, pp. 965-974
Authors:
Falcone, A
Allegrini, G
Lencioni, M
Pfanner, E
Brunetti, I
Cianci, C
Galli, C
Masi, G
Antonuzzo, A
Conte, P
Citation: A. Falcone et al., Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study, CANC CHEMOT, 44(2), 1999, pp. 159-163
Authors:
Cianci, C
Yu, KL
Dischino, DD
Harte, W
Deshpande, M
Luo, GX
Colonno, RJ
Meanwell, NA
Krystal, M
Citation: C. Cianci et al., pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusion, J VIROLOGY, 73(3), 1999, pp. 1785-1794
Authors:
Conte, PF
Cianci, C
Tanganelli, L
Gadducci, A
Cosio, S
Carnino, F
Jura, R
Citation: Pf. Conte et al., Paclitaxel (TAX), carboplatin (CBDCA) and epidoxorubicin (EPIDX) in advanced epithelial ovarian cancer (AEOC), 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 197-199
Authors:
Gadducci, A
Cianci, C
Carnino, F
Buttitta, F
Tanganelli, L
Chiara, S
Genazzani, AR
Conte, PF
Citation: A. Gadducci et al., p53 status and response to paclitaxel-based chemotherapy in patients with advanced epithelial ovarian cancer, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 207-210
Risultati:
1-11
|